Han-Jie Li

Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers

Yongsheng Yang, Shuang-feng Xu, L. Chang, 2022, Frontiers in Pharmacology.

Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience

Lin Qiu, Yingli Fu, Zhongshan Liu, 2022, Frontiers in Oncology.

TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers

Li-Ju Chang, J. Bian, Bingjin Li, 2021, Frontiers in Immunology.

lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis

R. Jing, Lei Cao, Yue Yao, 2019, OncoTargets and Therapy.

lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axis

R. Jing, Lei Cao, Yue Yao, 2019, OncoTargets and Therapy.

The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.

Han-Jie Li, Mingmei Huangfu, Hongliang Duan, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.